Genentech signs deal with Parvus to tackle inflammatory diseasesCanada’s Parvus Therapeutics has signed a deal with Roche’s Genentech unit to develop, manufacture and market drugs for Share XGenentech signs deal with Parvus to tackle inflammatory diseaseshttps://pharmaphorum.com/news/genentech-signs-deal-with-parvus-to-tackle-inflammatory-diseases/
